Ameritas Investment Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-229
Closed -$49.7K 2291
2021
Q1
$49.7K Buy
+229
New +$43K ﹤0.01% 964
2020
Q2
Sell
-589
Closed -$49K 1781
2020
Q1
$49K Buy
+589
New +$62.4K 0.01% 711
2019
Q4
Sell
-301
Closed -$37K 1649
2019
Q3
$37K Buy
+301
New +$45.7K 0.01% 751
2019
Q2
Sell
-252
Closed -$42K 952
2019
Q1
$42K Sell
252
-36
-13% -$5.36K 0.01% 456
2018
Q4
$28K Buy
+288
New +$37.8K 0.01% 769

Other funds holding GWPH

Ameritas Investment Company's GWPH Position: Q2 2021 in Review

Ameritas Investment Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 229 shares — an estimated $49.7K sold.

Ameritas Investment Company first reported a position in GWPH in Q4 2018 and held it in 5 quarters. The position peaked at $49.7K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Ameritas Investment Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 229 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $49.7K.
  • Ameritas Investment Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 5 quarters.
  • Ameritas Investment Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $49.7K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.